99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside GD2-positive tumors

This publication has 15 references indexed in Scilit:

• Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• [99mTc]Tricine: a Useful Precursor Complex for the Radiolabeling of Hydrazinonicotinate Protein Conjugates
  Bioconjugate Chemistry, 1995
• Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody MAb47: a comparison of labelling methods
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax.
  Proceedings of the National Academy of Sciences, 1993
• Search for New and Improved Radiolabeling Methods for Monoclonal Antibodies: A Review of Different Methods
  Acta Oncologica, 1993
• Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas
  Cancer, 1992
• Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.
  Proceedings of the National Academy of Sciences, 1988
• Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23
  JNCI Journal of the National Cancer Institute, 1986
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976